The DOI matches its Crossref record; 410 of the 410 references it cites were found in a registry or an index.
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
Open accessAbstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTThe Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic ApplicationsDidier M. Lambert and Christopher J. FowlerView Author Information Unité de Chimie Pharmaceutique et de Radiopharmacie, Université Catholique de Louvain, Avenue Mounier, 73, UCL-CMFA 73.40, B-1200 Brussels, Belgium, and Department of Pharmacology and Clinical Neuroscience, Umeå University, SE-901 87 Umeå, Sweden Cite this: J. Med. Chem. 2005, 48, 16, 5059–5087Publication Date (Web):July 19, 2005Publication History Received31 January 2005Published online19 July 2005Published inissue 1 August 2005https://pubs.acs.org/doi/10.1021/jm058183thttps://doi.org/10.1021/jm058183treview-articleACS PublicationsCopyright © 2005 American Chemical SocietyRequest reuse permissionsArticle Views3823Altmetric-Citations279LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Agonists,Inhibitors,Peptides and proteins,Receptors,Rodent models Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 410
Shearman, L. P., Rosko, K. M., Fleischer, R., Wang, J., Xu, S., Tong, X. S., & Rocha, B. A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200312000-00001 · Cited by 186
McAllister, S. D., Rizvi, G., Anavi-Goffer, S., Hurst, D. P., Barnett-Norris, J., Lynch, D. L., Reggio, P. H., & Abood, M. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0302647 · Cited by 185
Zlas, J., Stark, H., Seligman, J., Levy, R., Werker, E., Breuer, A., & Mechoulam, R. (1993) · Nature · doi:10.1038/363215a0 · Cited by 180
Veldhuis, W. B., van der Stelt, M., Wadman, M. W., van Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G. A., Vliegenthart, J. F. G., Bär, P. R., Nicolay, K., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04127.2003 · Cited by 179
Yoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K., & Kano, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01690.2002 · Cited by 179
Mallet, P. E., & Beninger, R. J. (1998) · Psychopharmacology · doi:10.1007/s002130050733 · Cited by 178
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi-Carmona, M., Shire, D., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 175
Nackley, A. G., Makriyannis, A., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00126-x · Cited by 174
Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors
Leggett, J. D., Aspley, S., Beckett, S. R. G., D'Antona, A. M., Kendall, D. A., & Kendall, D. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705607 · Cited by 174
Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
Bisogno, T., Melck, D., De Petrocellis, L., Bobrov, M. Y., Gretskaya, N. M., Bezuglov, V. V., Sitachitta, N., Gerwick, W. H., & Marzo, V. D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8874 · Cited by 173
Targeting the endocannabinoid system in cancer therapy: A call for further research
Bifulco, M., & Di Marzo, V. (2002) · Nature Medicine · doi:10.1038/nm0602-547 · Cited by 172
Melck, D., Rueda, D., Galve-Roperh, I., De Petrocellis, L., Guzmán, M., & Di Marzo, V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01639-7 · Cited by 168
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., et al. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00170-4 · Cited by 167
Tarzia, G., Duranti, A., Tontini, A., Piersanti, G., Mor, M., Rivara, S., Plazzi, P. V., Park, C., Kathuria, S., & Piomelli, D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021119g · Cited by 165
Saario, S. M., Savinainen, J. R., Laitinen, J. T., Järvinen, T., & Niemi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.003 · Cited by 163
Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice
Poncelet, M., Maruani, J., Calassi, R., & Soubrié, P. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00397-5 · Cited by 161
Cannabinoids in the treatment of glaucoma
Järvinen, T., Pate, D. W., & Laine, K. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00259-0 · Cited by 161
15-Lipoxygenase Metabolism of 2-Arachidonylglycerol
Kozak, K. R., Gupta, R. A., Moody, J. S., Ji, C., Boeglin, W. E., DuBois, R. N., Brash, A. R., & Marnett, L. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201084200 · Cited by 160
Savinainen, J. R., Järvinen, T., Laine, K., & Laitinen, J. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704297 · Cited by 159
Jonsson, K., Vandevoorde, S., Lambert, D. M., Tiger, G., & Fowler, C. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704199 · Cited by 158
Self-citationStructural Mimicry in Class A G Protein-coupled Receptor Rotamer Toggle Switches
McAllister, S. D., Hurst, D. P., Barnett‐Norris, J., Lynch, D. L., Reggio, P. H., & Abood, M. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406648200 · Cited by 156
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
Howlett, A. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90278-9 · Cited by 156
Maccarrone, M., Valensise, H. C. C., Bari, M., Lazzarin, N., Romaninï, C., & Finazzi‐Agrò, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7183 · Cited by 155
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., & Marzo, V. D. (2004) · The FASEB Journal · doi:10.1096/fj.04-1754fje · Cited by 154
Identification and characterisation of a novel splice variant of the human CB1 receptor
Ryberg, E., Vu, H. K., Larsson, N., Groblewski, T., Hjorth, S., Elebring, T., Sjögren, S., & Greasley, P. J. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.11.085 · Cited by 154
Anandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3
Sarker, K. P., Obara, S., Nakata, M., Kitajima, I., & Maruyama, I. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01425-3 · Cited by 153
van der Stelt, M., van Kuik, J. A., Bari, M., van Zadelhoff, G., Leeflang, B. R., Veldink, G. A., Finazzi‐Agrò, A., Vliegenthart, J. F. G., & Maccarrone, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020818q · Cited by 152
Patel, S., Wohlfeil, E. R., Rademacher, D. J., Carrier, E. J., Perry, L. J., Kundu, A., Falck, J. R., Nithipatikom, K., Campbell, W. B., & Hillard, C. J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705334 · Cited by 151
Further evidence for the existence of a specific process for the membrane transport of anandamide
Ligresti, A., Morera, E., van der Stelt, M., Monory, K., Lutz, B., Ortar, G., & Marzo, V. D. (2004) · Biochemical Journal · doi:10.1042/bj20031812 · Cited by 149
Novel selective and metabolically stable inhibitors of anandamide cellular uptake
Ortar, G., Ligresti, A., PETROCELLIS, L. D., Morera, E., & Marzo, V. D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00109-6 · Cited by 148
Chemically Distinct Ligands Promote Differential CB1 Cannabinoid Receptor-Gi Protein Interactions
Mukhopadhyay, S., & Howlett, A. C. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.003558 · Cited by 148
Yang, G., & Masland, R. H. (1992) · Science · doi:10.1126/science.1470920 · Cited by 146
From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis
Mechoulam, R., & Ben‐Shabat, S. (1999) · Natural Product Reports · doi:10.1039/a703973e · Cited by 145
Anticonvulsant Activity of N‐Palmitoylethanolamide, a Putative Endocannabinoid, in Mice
Lambert, D. M., Vandevoorde, S., Diependaele, G., Govaerts, S. J., & Robert, A. R. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.41499.x · Cited by 145
Self-citationCosta, B., Conti, S., Giagnoni, G., & Colleoni, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704900 · Cited by 143
Paria, B. C., Deutsch, D. D., & Dey, S. K. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199610)45:2<183::aid-mrd11>3.0.co;2-2 · Cited by 142
Smart, D., Jonsson, K., Vandevoorde, S., Lambert, D. M., & Fowler, C. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704732 · Cited by 140
Self-citationDifferential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain
Valenti, M., Vigan�, D., Casico, M. G., Rubino, T., Steardo, L., Parolaro, D., & Marzo, V. D. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3453-5 · Cited by 139
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
McFarland, M. J., Porter, A. C., Rakhshan, F., Rawat, D. S., Gibbs, R. A., & Barker, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407250200 · Cited by 139
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 139
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 138
Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., Blau, H., & Mechoulam, R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01295-0 · Cited by 138
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
Carlo, G. D., & Izzo, A. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.39 · Cited by 136
Boger, D. L., Henriksen, S. J., & Cravatt, B. F. (1998) · Current Pharmaceutical Design · doi:10.2174/138161280404221010152220 · Cited by 135
Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid Receptor
Deutsch, D. G., Lin, S., Hill, W. A. G., Morse, K. L., Salehani, D., Arreaza, G., Omeir, R. L., & Makriyannis, A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6072 · Cited by 134
Farquhar-Smith, P. W., Jaggar, S., & Rice, A. S. C. (2002) · Pain · doi:10.1016/s0304-3959(01)00419-5 · Cited by 133
Jarrahian, A., Manna, S., Edgemond, W. S., Campbell, W. B., & Hillard, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742597.x · Cited by 133
Walter, L. M., Dinh, T. P., & Stella, N. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2419-04.2004 · Cited by 132
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., & Martin, B. R. (1999) · PubMed · Cited by 132
Hampson, A. J., Hill, W. A. G., Zan-Phillips, M., Makriyannis, A., Leung, E., Eglen, R. M., & Bornheim, L. M. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00157-8 · Cited by 131
Weber, A., Ni, J., Ling, K.-H. J., Acheampong, A., Tang‐Liu, D. D., Burk, R. M., Cravatt, B. F., & Woodward, D. F. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300475-jlr200 · Cited by 130
Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
Katayama, K., Ueda, N., Kurahashi, Y., Suzuki, H., Yamamoto, S., & Kato, I. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00078-7 · Cited by 128
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism
Matias, I., Chen, J., PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H. ‐., Shi, L., Protzman, C. E., Li, C., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061705 · Cited by 128
Fezza, F., Bisogno, T., Minassi, A., Appendino, G., Mechoulam, R., & Marzo, V. D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02341-4 · Cited by 127
Mascia, M. S., Obinu, M. C., Ledent, C. A., Parmentier, M., Böhme, G. A., Impérato, A., & Fratta, W. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00656-1 · Cited by 125
Hohmann, A. G., Farthing, J. N., Zvonok, A. M., & Makriyannis, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060079 · Cited by 124
A role for endocannabinoids in indomethacin-induced spinal antinociception
Gühring, H., Hamza, M., Sergejeva, M., Ateş, M., Kotalla, C., Ledent, C. A., & Brune, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02485-8 · Cited by 123
Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Brandi, I., Jefferson, R. G., Winckler, R., Davis, J. B., DASSE, O. A., Mahadevan, A., Razdan, R. K., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4354 · Cited by 121
Pistis, M., Perra, S., Pillolla, G., Melis, M., Gessa, G. L., & Muntoni, A. L. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.003 · Cited by 120
Endocannabinoids in the immune system and cancer
Parolaro, D., Massi, P., Rubino, T., & Monti, E. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0355 · Cited by 119
ON THE THERAPEUTICAL USES AND TOXIC EFFECTS OF CANNABIS INDICA.
Reynolds, J. R. (1890) · The Lancet · doi:10.1016/s0140-6736(02)18723-x · Cited by 119
STRUCTURAL REQUIREMENTS FOR CANNABINOID ACTIVITY*
Edery, H., Grunfeld, Y., Ben‐Zvi, Z., et al. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb13985.x · Cited by 118
Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide Amidohydrolase
PETROCELLIS, L. D., Melck, D. J., Ueda, N., Maurelli, S., Kurahashi, Y., Yamamoto, S., Marino, G., & Marzo, V. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6000 · Cited by 117
Edgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., & Campbell, W. B. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.180 · Cited by 116
Patterson, J. E., Ollmann, I. R., Cravatt, B. F., Boger, D. L., Wong, C. H., & Lerner, R. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja954064z · Cited by 116
Inhibition of Anandamide Amidase Activity in Mouse Brain Microsomes by Cannabinoids.
Watanabe, K., Kayano, Y., Matsunaga, T., Yamamoto, I., & Yoshimura, H. (1996) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.19.1109 · Cited by 116
Rinaldi, M. L., Barth, F., Congy, C., Martinez, S., Oustric, D., Perio, A., Poncelet, M., Maruani, J., Arnone, M., Finance, O., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067884 · Cited by 115
Binding of anandamide to bovine serum albumin
Bojesen, I. N., & Hansen, H. S. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300170-jlr200 · Cited by 115
Paria, B. C., Ma, W., Andrenyak, D. M., Schmid, P. C., Schmid, H. H. O., Moody, D. E., Deng, H., Makriyannis, A., & Dey, S. K. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.6.1490 · Cited by 113
Endocannabinoids and related fatty acid derivatives in pain modulation
Walker, J. M., Krey, J. F., Chu, C. J., & Huang, S. M. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00152-4 · Cited by 113
Lambert, D. M., DiPaolo, F. G., Sonveaux, P., Kanyonyo, M. R., Govaerts, S. J., Hermans, E., Bueb, J., Delzenne, N. M., & Tschirhart, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00132-8 · Cited by 113
Self-citationInduction of the mammalian node requires Arkadia function in the extraembryonic lineages
Episkopou, V., Arkell, R. M., Timmons, P. M., Walsh, J. J., Andrew, R. L., & Swan, D. (2001) · Nature · doi:10.1038/35071095 · Cited by 112
Savinainen, J. R., Saario, S. M., Niemi, R., Järvinen, T., & Laitinen, J. T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705577 · Cited by 112
Boger, D. L., Sato, H., Lerner, A. E., Austin, B. J., Patterson, J. E., Patricelli, M. P., & Cravatt, B. F. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00734-3 · Cited by 110
Ross, R. A., Craib, S. J., Stevenson, L., Pertwee, R. G., Henderson, A., Toole, J. J., & Ellington, H. C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.900 · Cited by 110
Terrazzino, S., Berto, F., Carbonare, M. D., Fabris, M., Guiotto, A., Bernardini, D., & Leon, A. (2004) · The FASEB Journal · doi:10.1096/fj.03-1080fje · Cited by 109
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
Calandra, B., Portier, M., Kernéis, A., Delpech, M., Carillon, C., Fur, G. L., Ferrara, P., & Shire, D. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00349-0 · Cited by 108
Ford, W. R., Honan, S. A., White, R., & Hiley, C. R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704565 · Cited by 107
Govaerts, S. J., Hermans, E., & Lambert, D. M. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.07.013 · Cited by 107
Self-citationADAMS, R. L. P., Baker, B. R., & Wearn, R. B. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01865a083 · Cited by 107
Leung, D., Du, W., Hardouin, C., Cheng, H. W., Hwang, I., Cravatt, B. F., & Boger, D. L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.085 · Cited by 106
Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice
Járai, Z., Wagner, J. A., Goparaju, S. K., Wang, L., Razdan, R. K., Sugiura, T., Zimmer, A. M., Bonner, T. I., Zimmer, A. D., & Kunos, G. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.679 · Cited by 105
Yamaguchi, T., Hagiwara, Y., Tanaka, H., Sugiura, T., Waku, K., Shoyama, Y., Watanabe, S., & Yamamoto, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02655-5 · Cited by 104
Sarker, K. P., & Maruyama, I. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3055-2 · Cited by 104
Anandamide hydrolysis: a new target for anti-anxiety drugs?
Gaetani, S., Cuomo, V., & Piomelli, D. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.09.005 · Cited by 104
Ghafouri, N., Tiger, G., Razdan, R. K., Mahadevan, A., Pertwee, R. G., Martin, B. R., & Fowler, C. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705948 · Cited by 104
Self-citationBinding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells
Maccarrone, M., Pauselli, R., Rienzo, M. D., & Finazzi‐Agrò, A. (2002) · Biochemical Journal · doi:10.1042/bj20020438 · Cited by 104
An acid amidase hydrolyzing anandamide as an endogenous ligand forcannabinoid receptors
Ueda, N., Yamanaka, K., Terasawa, Y., & Yamamoto, S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00820-0 · Cited by 103
Food intake is inhibited by oral oleoylethanolamide
Nielsen, M. J., Petersen, G. L., Astrup, A. V., & Hansen, H. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.c300008-jlr200 · Cited by 103
Isolation and expression of a mouse CB1 cannabinoid receptor gene
Abood, M. E., Ditto, K. E., Noel, M. A., Showalter, V. M., & Tao, Q. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00727-7 · Cited by 102
Abadji, V., Lucas-Lenard, J. M., Chin, C., & Kendall, D. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722032.x · Cited by 101
Fowler, C. J., Tiger, G., Ligresti, A., López-Rodríguez, M. L., & Marzo, V. D. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.03.048 · Cited by 101
Self-citationOleoylethanolamide inhibits food intake in free-feeding rats after oral administration
Oveisi, F. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.006 · Cited by 100
Chemical stability of 2-arachidonylglycerol under biological conditions
Rouzer, C. A., Ghebreselasie, K., & Marnett, L. J. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00068-3 · Cited by 100
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 99
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors
Mukherjee, S., Adams, M., Whiteaker, K. L., Daza, A. V., Kage, K., Cassar, S. C., Meyer, M., & Yao, B. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.058 · Cited by 99
Mauler, F., Mittendorf, J., Horváth, E., & Vry, J. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.359 · Cited by 99
Luk, T., Jin, W., Zvonok, A. M., Lu, D., Lin, X., Chavkin, C., Makriyannis, A., & Mackie, K. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705792 · Cited by 99
Vivian, J. A., Kishioka, S., Butelman, E. R., Broadbear, J., Lee, K. O., & Woods, J. H. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37642-6 · Cited by 98
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake
de Lago, E., Ligresti, A., Ortar, G., Morera, E., Cabranes, A., Pryce, G., Bifulco, M., Baker, D., Fernández‐Ruíz, J., & Marzo, V. D. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.11.027 · Cited by 98
Oka, S., Tsuchie, A., Tokumura, A., Muramatsu, M., Suhara, Y., Takayama, H., Waku, K., & Sugiura, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01804.x · Cited by 96
Behavioral, Pharmacological, and Molecular Characterization of an Amphibian Cannabinoid Receptor
Soderstrom, K., Leid, M. E., Moore, F. L., & Murray, T. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750413.x · Cited by 95
Ortega‐Gutiérrez, S., Hawkins, E. G., Viso, A., López-Rodríguez, M. L., & Cravatt, B. F. (2004) · Biochemistry · doi:10.1021/bi049395f · Cited by 93
Ruiu, S., Pinna, G. A., Marchese, G., Mussinu, J., Saba, P., Tambaro, S., Casti, P., Vargiu, R., & Pani, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049924 · Cited by 93
Possible involvement of the endocannabinoid system in the actions of three clinically used drugs
Fowler, C. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.12.001 · Cited by 91
Self-citationMartin, B. R., Jefferson, R. G., Winckler, R., Wiley, J. L., Huffman, J. W., Crocker, P. J., Saha, B., & Razdan, R. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35007-4 · Cited by 91
McFarland, M. J., & Barker, E. L. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.07.008 · Cited by 91
Membrane Cholesterol But Not Putative Receptors Mediates Anandamide–Induced Hepatocyte Apoptosis
Biswas, K. K., Sarker, K. P., Abeyama, K., Kawahara, K.-I., Iino, S., Otsubo, Y., Saigo, K., Izumi, H., Hashiguchi, T., Yamakuchi, M., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50459 · Cited by 90
Craib, S. J., Ellington, H. C., Pertwee, R. G., & Ross, R. A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704223 · Cited by 89
Boger, D. L., Miyauchi, H., & Hedrick, M. P. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00211-6 · Cited by 89
Kishimoto, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh063 · Cited by 88
PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Bifulco, M., Melck, D. J., & Marzo, V. D. (2002) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2002.00094.x · Cited by 88
Exon–intron organization and chromosomal localization of the mouse monoglyceride lipase gene
Karlsson, M., Reue, K., Xia, Y.-R., Lusis, A. J., Langin, D., Tornqvist, H. E., & Holm, C. (2001) · Gene · doi:10.1016/s0378-1119(01)00559-5 · Cited by 87
Leptin Activates the Anandamide Hydrolase Promoter in Human T Lymphocytes through STAT3
Maccarrone, M., Rienzo, M. D., Finazzi‐Agrò, A., & Rossi, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211248200 · Cited by 87
Rockwell, C. E., & Kaminski, N. E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.065524 · Cited by 86
López-Rodríguez, M. L., Viso, A., Ortega‐Gutiérrez, S., Fowler, C. J., Tiger, G., de Lago, E., Fernández‐Ruíz, J., & Ramos, J. A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0210818 · Cited by 82
Self-citationAteş, M., Hamza, M., Seidel, K., Kotalla, C., Ledent, C. A., & Gühring, H. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02470.x · Cited by 78
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Reggio, P. H. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454577 · Cited by 78
Johanek, L. M., & Simone, D. A. (2004) · Pain · doi:10.1016/j.pain.2004.02.020 · Cited by 78
Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents
Fowler, C. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00218-7 · Cited by 78
Self-citationThe endocannabinoid signaling system: Pharmacological and therapeutic aspects
Fowler, C. J., Holt, S., Nilsson, O. R., Jonsson, K., Tiger, G., & Jacobsson, S. O. P. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.023 · Cited by 77
Self-citationFowler, C. J., Tiger, G., & Stenström, A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37038-7 · Cited by 76
Self-citationOleamide and anandamide effects on food intake and sexual behavior of rats
Martínez-González, D., Bonilla‐Jaime, H., Morales-Otal, A., Henriksen, S. J., Velázquez‐Moctezuma, J., & Prospero-Garcia, O. E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.03.080 · Cited by 76
6ʺ-Azidohex-2ʺ-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist
Thomas, A., Ross, R. A., Saha, B., Mahadevan, A., Razdan, R. K., & Pertwee, R. G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.01.023 · Cited by 76
Steffens, M., & Feuerstein, T. J. (2003) · Neurochemistry International · doi:10.1016/j.neuint.2003.08.009 · Cited by 75
Yamaji, K., Sarker, K. P., Kawahara, K., Iino, S., Yamakuchi, M., Abeyama, K., Hashiguchi, T., & Maruyama, I. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613475 · Cited by 74
Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides
Patricelli, M. P., & Cravatt, B. F. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)62002-8 · Cited by 73
Endogenous cannabinoids: Metabolism and their role in reproduction
Habayeb, O. M. H., Bell, S. C., & Konje, J. C. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01539-9 · Cited by 73
Phylogenomic and chemotaxonomic analysis of the endocannabinoid system
McPartland, J. M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.11.005 · Cited by 72
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco, G., Galve‐Roperh, I., Sánchez, C., Blázquez, C., & Guzmán, M. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.04.016 · Cited by 72
Barnett‐Norris, J., Guarnieri, F., Hurst, D. P., & Reggio, P. H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9803471 · Cited by 72
Köfalvi, A., Vizi, E. S., Ledent, C. A., & Sperlágh, B. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02897.x · Cited by 71
Inhibition of Anandamide Hydrolysis by the Enantiomers of Ibuprofen, Ketorolac, and Flurbiprofen
Fowler, C. J., Janson, U., Johnson, R. M., Wahlström, G., Stenström, A., Norström, Å., & Tiger, G. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1025 · Cited by 71
Self-citationTsuboi, K., HILLIGSMANN, C., Vandevoorde, S., Lambert, D. M., & Ueda, N. (2004) · Biochemical Journal · doi:10.1042/bj20031695 · Cited by 70
Self-citationBouaboula, M., Bianchini, L., McKenzie, F. R., Pouysségur, J., & Casellas, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00395-6 · Cited by 70
Fowler, C. J., & Jacobsson, S. O. P. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0357 · Cited by 69
Self-citationMicrosomal cytochrome P450-mediated liver and brain anandamide metabolism
Bornheim, L. M., Kim, K. Y., Chen, B., & Correia, M. A. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00177-2 · Cited by 68
Roche, J. P., Bounds, S., Brown, S. M., & Mackie, K. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.611 · Cited by 68
Regulation of anandamide tissue levels by N-arachidonylglycine
BURSTEIN, S. H., Huang, S. M., Petros, T. J., Rossetti, R. G., Walker, J. M., & Zurier, R. B. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01301-1 · Cited by 67
Maccarrone, M., Cartoni, A., Parolaro, D., Margonelli, A., Massi, P., Bari, M., Battista, N., & Finazzi‐Agrò, A. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1164 · Cited by 67
Pertwee, R. G., Griffin, G., Lainton, J. A. H., & Huffman, J. W. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00318-f · Cited by 67
Barg, J., Fride, E., Hanus, L. O., Levy, R., Matus-Leibovitch, N., Heldman, E., Bayewitch, M. L., Mechoulam, R., & Vogel, Z. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00487-4 · Cited by 67
O‐1057, a potent water‐soluble cannabinoid receptor agonist with antinociceptive properties
Pertwee, R. G., Gibson, T. M., Stevenson, L., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703245 · Cited by 65
Amino Acid Determinants in Cyclooxygenase-2 Oxygenation of the Endocannabinoid 2-Arachidonylglycerol
Kozak, K. R., Prusakiewicz, J. J., Rowlinson, S. W., Schneider, C. G., & Marnett, L. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104467200 · Cited by 65
Stefano, G. B., Bilfinger, T. V., Rialas, C. M., & Deutsch, D. G. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0702 · Cited by 64
Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor
Barnett‐Norris, J., Hurst, D. P., Lynch, D. L., Guarnieri, F., Makriyannis, A., & Reggio, P. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0200761 · Cited by 64
Hájos, N., Kathuria, S., Dinh, T. P., Piomelli, D., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03433.x · Cited by 64
De Vry, J., Denzer, D., Reissmueller, E., Eijckenboom, M., Heil, M., Meier, H., & Mauler, F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062836 · Cited by 63
Microsomal Synthesis of Fatty Acid Amides
Bachur, N. R., & Udenfriend, S. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96775-x · Cited by 63
(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only
Fride, E., Feigin, C., Ponde, D. E., Breuer, A., Hanuš, L., Arshavsky, N., & Mechoulam, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.049 · Cited by 62
Muccioli, G. G., Martin, D. V., Scriba, G. K. E., Poppitz, W., Poupaert, J. H., Wouters, J., & Lambert, D. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049263k · Cited by 62
Self-citationCB1 cannabinoid receptor expression in brain regions associated with zebra finch song control
Soderstrom, K., & Johnson, F. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02393-8 · Cited by 62
Oleamide: a member of the endocannabinoid family?
Fowler, C. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705608 · Cited by 60
Self-citationAn endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase
Patricelli, M. P., Patterson, J. E., Boger, D. L., & Cravatt, B. F. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00073-0 · Cited by 59
Ramer, R., Weinzierl, U., Schwind, B., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1189 · Cited by 59
Anandamide amidohydrolase (fatty acid amide hydrolase)
Ueda, N., & Yamamoto, S. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00052-6 · Cited by 58
Kelly, S., Jhaveri, M. D., Sagar, D. R., Kendall, D. A., & Chapman, V. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02957.x · Cited by 58
Laine, K., Järvinen, K., Mechoulam, R., Breuer, A., & Järvinen, T. (2002) · PubMed · Cited by 56
Distribution and characterization of anandamide amidohydrolase in mouse brain and liver
Watanabe, K., Ogi, H., Nakamura, S., Kayano, Y., Matsunaga, T., Yoshimura, H., & Yamamoto, I. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00052-6 · Cited by 56
Baker, C., & McDougall, J. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705902 · Cited by 56
Ueda, N., Liu, Q., & Yamanaka, K. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(01)00120-2 · Cited by 55
Berding, G., Müller-Vahl, K., Schneider, U., Gielow, P., Fitschen, J., Stuhrmann, M., Harke, H., Buchert, R., Donnerstag, F., Hofmann, M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.005 · Cited by 54
Paria, B. C., Zhao, X., Wang, J., Das, S., & Dey, S. K. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.5.1151 · Cited by 54
Fluctuations of fatty acid amide hydrolase and anandamide levels during the human ovulatory cycle
Lazzarin, N., Valensise, H. C. C., Bari, M., Ubaldi, F., Battista, N., Finazzi‐Agrò, A., & Maccarrone, M. (2004) · Gynecological Endocrinology · doi:10.1080/09513590410001692492 · Cited by 54
Zebra Finch CB1 Cannabinoid Receptor: Pharmacology and in Vivo and in Vitro Effects of Activation
Soderstrom, K., & Johnson, F. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29527-6 · Cited by 54
Fowler, C. J., Holt, S., & Tiger, G. (2003) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/1475636021000049726 · Cited by 53
Self-citationBaskfield, C. Y., Martin, B. R., & Wiley, J. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055376 · Cited by 50
Murphy, J. W., & Kendall, D. A. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00155-2 · Cited by 49
Rhee, M. H., Nevo, I., Levy, R., & Vogel, Z. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01094-2 · Cited by 46
Cannabinoid Properties of Methylfluorophosphonate Analogs
Martin, B. R., Beletskaya, I., Patrick, G., Jefferson, R. G., Winckler, R., Deutsch, D. G., Marzo, V. D., Dasse, O. A., Mahadevan, A., & Razdan, R. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39191-8 · Cited by 46
Fowler, C. J., Jonsson, K., Andersson, A., Juntunen, J., Järvinen, T., Vandevoorde, S., Lambert, D. M., Jerman, J. C., & Smart, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00392-7 · Cited by 45
Self-citationEdgemond, W. S., Greenberg, M. J., McGinley, P. J., Muthian, S., Campbell, W. B., & Hillard, C. J. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37574-3 · Cited by 45
Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor‐deficient mice
Kathmann, M., Weber, B., Zimmer, A., et al. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703987 · Cited by 44
Vandevoorde, S., Tsuboi, K., Ueda, N., Jonsson, K., Fowler, C. J., & Lambert, D. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0340795 · Cited by 44
Self-citationActivation of N-acylethanolamine-releasing phospholipase D by polyamines
Liu, Q., Tonai, T., & Ueda, N. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00015-4 · Cited by 43
Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen
Holt, S., Nilsson, J., Omeir, R. L., Tiger, G., & Fowler, C. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704113 · Cited by 43
Self-citationOoms, F., Wouters, J., Oscari, O., Happaerts, T., Bouchard, G., Carrupt, P., Testa, B., & Lambert, D. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010896y · Cited by 43
Self-citationKelley, B. G., & Thayer, S. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.011 · Cited by 42
Basso, E., Duranti, A., Mor, M., Piomelli, D., Tontini, A., Tarzia, G., & Traldi, P. (2004) · Journal of Mass Spectrometry · doi:10.1002/jms.729 · Cited by 42
Methanandamide increases COX‐2 expression and tumor growth in murine lung cancer
Gardner, B. K., Zhu, L. X., Sharma, S. P., Tashkin, D. P., & Dubinett, S. M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0254fje · Cited by 41
Beltramo, M., di Tomaso, E., & Piomelli, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00061-6 · Cited by 40
Vandevoorde, S., Jonsson, K., Fowler, C. J., & Lambert, D. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0209679 · Cited by 40
Self-citationGulaya, N. M., Kuzmenko, A. I., Margitich, V. M., Govseeva, N. M., Melnichuk, S. D., Tm, H., & Zhukov, A. D. (1998) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(98)00093-0 · Cited by 39
Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase
Fowler, C. J., Börjesson, M., & Tiger, G. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703569 · Cited by 38
Self-citationReceptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro
Bueb, J., Lambert, D. M., & Tschirhart, E. J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00076-3 · Cited by 38
Self-citationHo, W. ‐. V., & Hiley, C. R. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023682 · Cited by 38
Karlsson, M., Påhlsson, C., & Fowler, C. J. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.03.009 · Cited by 37
Self-citationWiley, J. L., LaVecchia, K. L., Karp, N. E., et al. (2004) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.12.3.173 · Cited by 37
THE RELATIVE ACTIVITY OF VARIOUS PURIFIED PRODUCTS OBTAINED FROM AMERICAN GROWN HASHISH
WALTON, R. P., Martin, L., & KELLER, J. H. (1938) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09020-2 · Cited by 34
Looking Back at Cannabis Research
Mechoulam, R. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399509 · Cited by 33
Morozov, Y. M., Ben‐Ari, Y., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03507.x · Cited by 33
Subcellular Localization and Some Properties of Monoacyiglycerol Lipase in Rat Adipocytes
SAKURADA, T., & Noma, A. (1981) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133607 · Cited by 31
Kojima, S., Sugiura, T., Waku, K., & Kamikawa, Y. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01650-3 · Cited by 31
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist
van Oosten, B. W., Killestein, J., Mathus-Vliegen, E. M. H., & Polman, C. H. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1044oa · Cited by 31
Stanke‐Labesque, F., MALLARET, M., LEFEBVRE, B., HARDY, G., Caron, F., & Bessard, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.024 · Cited by 28
Segall, Y., Quistad, G. B., Nomura, D. K., & Casida, J. E. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00721-2 · Cited by 26
Focus on the Three Key Enzymes Hydrolysing Endocannabinoids as New Drug Targets
Vandevoorde, S., & Lambert, D. M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054546914 · Cited by 26
Self-citationHolt, S., & Fowler, C. J. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0686-z · Cited by 25
Self-citationDuncan, M., Kendall, D. A., & Ralevic, V. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067587 · Cited by 23
Jonsson, K., Andersson, A., Jacobsson, S. O. P., Vandevoorde, S., Lambert, D. M., & Fowler, C. J. (2003) · Archives of Toxicology · doi:10.1007/s00204-002-0435-6 · Cited by 23
Self-citation
Cited by
ESPEN guidelines on nutrition in cancer patients
Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Fearon, K., Hütterer, E., Isenring, E., Kaasa, S., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2016.07.015 · Cited by 3,114
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Drug treatments for obesity: orlistat, sibutramine, and rimonabant
Padwal, R. S., & Majumdar, S. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60033-6 · Cited by 753
Organic Carbamates in Drug Design and Medicinal Chemistry
Ghosh, A. K., & Brindisi, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501371s · Cited by 739
Metadata
- Authors
- Lambert, D. M., & Fowler, C. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-07-19
- Volume
- 48
- Issue
- 16
- Pages
- 5059-5087
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1988800581
- Cited by
- 350
- References
- 410
- FWCI
- 20.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.